Biogen Cancels Another Dementia Drug in Phase 2 Clinical Trial
Biogen announced this week that it was cancelling the dementia drug it was testing in a Phase 2 trial that aimed to fight tau…
Biogen announced this week that it was cancelling the dementia drug it was testing in a Phase 2 trial that aimed to fight tau…
Chronic traumatic encephalopathy, or CTE, is a form of dementia caused by repeated traumatic brain injuries — it’s commonly associated with contact sports, and…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…
In a new study published in JAMA Neurology, researchers reported the first results of an initial basket trial for neurodegenerative diseases. The trial brings…
Scientists at Northwestern Medicine have pinpointed the location of of the brain networks that can lead to primary progressive aphasia (PPA), which is a…
September 4th, 2019 I was the principal caregiver for my wife, Carole. I retired earlier than planned because Carole needed more help at home….
Katie Brandt, MM, the Director of Caregiver Support Services and Public Relations for the Massachusetts General Hospital Frontotemporal Disorders Unit, discusses how her late…
Lead researcher and neurology professor at the University of Miami Dr. Deborah Mash is studying the link between Alzheimer’s signs in dolphins and humans….
Before being diagnosed with cerebral microvascular disease, a precursor to vascular dementia, at age 61, Gerda Saunders noticed she was having trouble with her…
Some people who have been diagnosed with Alzheimer’s may actually have a newly defined type of dementia that mimics the disease’s symptoms but is…
People living with dementia and their caregivers often feel as if they have nowhere to turn after a diagnosis. Many caregivers need help navigating…
After an Alzheimer’s diagnosis, many caregivers and patients feel as if they are sent away with a pamphlet, pills and little concrete advice on…
Leading caregiving expert Teepa Snow has studied how brain function changes after a dementia diagnosis and how understanding these changes can improve the ways…
Clinical trial participants, researchers and investors were reeling on Thursday after Biogen and Eisai, its Japanese pharmaceutical partner, announced that they would be halting two…
Dementia is steadily rising in the ranks of causes of death in America, according to a new report released by the National Center for…